The FOS transcription factor family differentially controls trophoblast migration and invasion

Journal of Biological Chemistry

Volumn 289, Issue 8, 2014, Pages 5025-5039

  Renaud, Stephen J ^a   Kubota, Kaiyu ^a   Rumi, M A Karim ^a   Soares, Michael J ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGY;

BLOOD FLOW;

TRANSCRIPTION FACTORS;

INTERSTITIAL COLLAGENASE; PROTEIN FOS; PROTEIN FOSL1; STROMELYSIN; STROMELYSIN 2; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL POPULATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; FOSL1 GENE; GENE; GENE SILENCING; GENETIC TRANSCRIPTION; GESTATIONAL AGE; HUMAN; HUMAN CELL; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; TROPHOBLAST;

EMBRYO IMPLANTATION; PLACENTA; PREGNANCY; REPRODUCTION; TROPHOBLAST;

CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LAMININ; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MULTIGENE FAMILY; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; RNA, SMALL INTERFERING; TROPHOBLASTS;

EID: 84894431112     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.523746     Document Type: Article

References (67)

1. Pijnenborg, R., Vercruysse, L., and Hanssens, M. (2006) The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27, 939-958
2. Brosens, J. J., Pijnenborg, R., and Brosens, I. A. (2002) The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am. J. Obstet. Gynecol. 187, 1416-1423
3. Tantbirojn, P., Crum, C. P., and Parast, M. M. (2008) Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta 29, 639-645
4. Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A. P., and Bellet, D. (2007) Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum. Reprod. Update 13, 121-141
5. Soundararajan, R., and Rao, A. J. (2004) Trophoblast 'pseudo- tumorigenesis': significance and contributory factors. Reprod. Biol. Endocrinol. 2, 15
6. Hess, J., Angel, P., and Schorpp-Kistner, M. (2004) AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117, 5965-5973
7. Benbow, U., and Brinckerhoff, C. E. (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15, 519-526
8. Monje, P., Marinissen, M. J., and Gutkind, J. S. (2003) Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol. 23, 7030-7043
9. Casalino, L., De Cesare, D., and Verde, P. (2003) Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol. Cell. Biol. 23, 4401-4415
10. Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E., and Leder, P. (1988) c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55, 917-924
11. Ryseck, R. P., and Bravo, R. (1991) c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene 6, 533-542
12. Schütte, J., Viallet, J., Nau, M., Segal, S., Fedorko, J., and Minna, J. (1989) jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59, 987-997
13. Reichmann, E., Schwarz, H., Deiner, E. M., Leitner, I., Eilers, M., Berger, J., Busslinger, M., and Beug, H. (1992) Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelialfibroblastoid cell conversion. Cell 71, 1103-1116
14. Saez, E., Rutberg, S. E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S. H., and Spiegelman, B. M. (1995) c-fos is required for malignant progression of skin tumors. Cell 82, 721-732
15. Hu, E., Mueller, E., Oliviero, S., Papaioannou, V. E., Johnson, R., and Spiegelman, B. M. (1994) Targeted disruption of the c-fos gene demonstrates c-fos-dependent and-independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13, 3094-3103
16. Kovary, K., Rizzo, C. A., Ryseck, R. P., Noguchi, T., Raynoschek, C., Pelosin, J. M., and Bravo, R. (1991) Constitutive expression of FosB and its short form, FosB/SF, induces malignant cell transformation in rat-1A cells. New Biol. 3, 870-879
17. Young, M. R., and Colburn, N. H. (2006) Fra-1 a target for cancer prevention or intervention. Gene 379, 1-11
18. Zajchowski, D. A., Bartholdi, M. F., Gong, Y., Webster, L., Liu, H. L., Munishkin, A., Beauheim, C., Harvey, S., Ethier, S. P., and Johnson, P. H. (2001) Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 61, 5168-5178
19. Kustikova, O., Kramerov, D., Grigorian, M., Berezin, V., Bock, E., Lukanidin, E., and Tulchinsky, E. (1998) Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol. Cell. Biol. 18, 7095-7105
20. Ramos-Nino, M. E., Scapoli, L., Martinelli, M., Land, S., and Mossman, B. T. (2003) Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma. Cancer Res. 63, 3539-3545
21. Tkach, V., Tulchinsky, E., Lukanidin, E., Vinson, C., Bock, E., and Berezin, V. (2003) Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene 22, 5045-5054
22. Schreiber, M., Wang, Z. Q., Jochum, W., Fetka, I., Elliott, C., and Wagner, E. F. (2000) Placental vascularisation requires the AP-1 component fra1. Development 127, 4937-4948
23. Kent, L. N., Rumi, M. A., Kubota, K., Lee, D. S., and Soares, M. J. (2011) FOSL1 is integral to establishing the maternal-fetal interface. Mol. Cell. Biol. 31, 4801-4813
24. Bozec, A., Bakiri, L., Hoebertz, A., Eferl, R., Schilling, A. F., Komnenovic, V., Scheuch, H., Priemel, M., Stewart, C. L., Amling, M., and Wagner, E. F. (2008) Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature 454, 221-225
25. Marzioni, D., Todros, T., Cardaropoli, S., Rolfo, A., Lorenzi, T., Ciarmela, P., Romagnoli, R., Paulesu, L., and Castellucci, M. (2010) Activating protein-1 family of transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction. Placenta 31, 919-927
26. Briese, J., Sudahl, S., Schulte, H. M., Löning, T., and Bamberger, A. M. (2005) Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions. Int. J. Gynecol. Pathol. 24, 265-270
27. Bamberger, A. M., Bamberger, C. M., Aupers, S., Milde-Langosch, K., Löning, T., and Makrigiannakis, A. (2004) Expression pattern of the activating protein-1 family of transcription factors in the human placenta. Mol. Hum. Reprod. 10, 223-228
28. Bischof, P. (2001) Endocrine, paracrine and autocrine regulation of trophoblastic metalloproteinases. Early Pregnancy 5, 30-31
29. Bischof, P., Truong, K., and Campana, A. (2003) Regulation of trophoblastic gelatinases by proto-oncogenes. Placenta 24, 155-163
30. Pattillo, R. A., and Gey, G. O. (1968) The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res. 28, 1231-1236
31. Hussa, R. O., Story, M. T., and Pattillo, R. A. (1975) Regulation of human chorionic gonadotropin (hCG) secretion by serum and dibutyryl cyclic AMPin malignant trophoblast cells in vitro. J. Clin. Endocrinol. Metab. 40, 401-405
32. Kohler, P. O., and Bridson, W. E. (1971) Isolation of hormone-producing clonal lines of human choriocarcinoma. J. Clin. Endocrinol. Metab. 32, 683-687
33. Graham, C. H., Hawley, T. S., Hawley, R. G., MacDougall, J. R., Kerbel, R. S., Khoo, N., and Lala, P. K. (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp. Cell Res. 206, 204-211
34. Straszewski-Chavez, S. L., Abrahams, V. M., Alvero, A. B., Aldo, P. B., Ma, Y., Guller, S., Romero, R., and Mor, G. (2009) The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan. Placenta 30, 939-948
35. Choy, M. Y., and Manyonda, I. T. (1998) The phagocytic activity of human first trimester extravillous trophoblast. Hum. Reprod. 13, 2941-2949
36. Lewis, M. P., Clements, M., Takeda, S., Kirby, P. L., Seki, H., Lonsdale, L. B., Sullivan, M. H., Elder, M. G., and White, J. O. (1996) Partial characterization of an immortalized human trophoblast cell-line, TCL-1, which possesses a CSF-1 autocrine loop. Placenta 17, 137-146
37. Cory, G. (2011) Scratch-wound assay. Methods Mol. Biol. 769, 25-30
38. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675
39. Lee, D. S., Rumi, M. A., Konno, T., and Soares, M. J. (2009) In vivo genetic manipulation of the rat trophoblast cell lineage using lentiviral vector delivery. Genesis 47, 433-439
40. Highet, A. R., Zhang, V. J., Heinemann, G. K., and Roberts, C. T. (2012) Use of Matrigel in culture affects cell phenotype and gene expression in the first trimester trophoblast cell line HTR8/SVneo. Placenta 33, 586-588
41. Hu, Y., Eastabrook, G., Tan, R., MacCalman, C. D., Dutz, J. P., and von Dadelszen, P. (2010) Decidual NK cell-derived conditioned medium enhances capillary tube and network organization in an extravillous cytotrophoblast cell line. Placenta 31, 213-221
42. Fukushima, K., Murata, M., Hachisuga, M., Tsukimori, K., Seki, H., Takeda, S., Kato, K., and Wake, N. (2008) Gene expression profiles by microarray analysis during Matrigel-induced tube formation in a human extravillous trophoblast cell line: comparison with endothelial cells. Placenta 29, 898-904
43. Borden, P., and Heller, R. A. (1997) Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7, 159-178
44. Basbous, J., Chalbos, D., Hipskind, R., Jariel-Encontre, I., and Piechaczyk, M. (2007) Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique Cterminal destabilizer. Mol. Cell. Biol. 27, 3936-3950
45. Mackeigan, J. P., Murphy, L. O., Dimitri, C. A., and Blenis, J. (2005) Graded mitogen-activated protein kinase activity precedes switch-like c-Fos induction in mammalian cells. Mol. Cell. Biol. 25, 4676-4682
46. Hill, C. S., Wynne, J., and Treisman, R. (1994) Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J. 13, 5421-5432
47. Kumar, S., Jiang, M. S., Adams, J. L., and Lee, J. C. (1999) Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 263, 825-831
48. Apps, R., Murphy, S. P., Fernando, R., Gardner, L., Ahad, T., and Moffett, A. (2009) Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127, 26-39
49. Aboagye-Mathiesen, G., Laugesen, J., Zdravkovic, M., and Ebbesen, P. (1996) Isolation and characterization of human placental trophoblast subpopulations from first-trimester chorionic villi. Clin. Diagn. Lab. Immunol. 3, 14-22
50. Shin, S., Dimitri, C. A., Yoon, S. O., Dowdle, W., and Blenis, J. (2010) ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol. Cell 38, 114-127
51. Andreolas, C., Kalogeropoulou, M., Voulgari, A., and Pintzas, A. (2008) Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells. Int. J. Cancer 122, 1745-1756
52. Pai, S. R., and Bird, R. C. (1994) c-fos expression is required during all phases of the cell cycle during exponential cell proliferation. Anticancer Res. 14, 985-994
53. Parrales, A., Palma-Nicolás, J. P., López, E., and López-Colomé, A. M. (2010) Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression. J. Cell. Physiol. 222, 302-312
54. Güller, M., Toualbi-Abed, K., Legrand, A., Michel, L., Mauviel, A., Bernuau, D., and Daniel, F. (2008) c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear cyclin D1. World J. Gastroenterol. 14, 6339-6346
55. Crowe, D. L., Brown, T. N., Kim, R., Smith, S. M., and Lee, M. K. (2000) A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines. Mol. Cell Biol. Res. Commun. 3, 243-248
56. Kovary, K., and Bravo, R. (1991) Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11, 2451-2459
57. Brüsselbach, S., Möhle-Steinlein, U., Wang, Z. Q., Schreiber, M., Lucibello, F. C., Müller, R., and Wagner, E. F. (1995) Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene 10, 79-86
58. Balsalobre, A., and Jolicoeur, P. (1995) Fos proteins can act as negative regulators of cell growth independently of the fos transforming pathway. Oncogene 11, 455-465
59. Koizumi, T., Ochi, Y., Kobayashi, S., Nakanishi, M., and Tokuhisa, T. (1994) Deregulated expression of c-fos disturbs proliferative responses of B cells to sIg cross-linking. Cell. Immunol. 155, 384-393
60. Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F., and Karin, M. (2000) The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 103, 897-907
61. Fleischmann, A., Hafezi, F., Elliott, C., Remé, C. E., Rüther, U., and Wagner, E. F. (2000) Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev. 14, 2695-2700
62. Genbacev, O., Zhou, Y., Ludlow, J. W., and Fisher, S. J. (1997) Regulation of human placental development by oxygen tension. Science 277, 1669-1672
63. Tarrade, A., Goffin, F., Munaut, C., Lai-Kuen, R., Tricottet, V., Foidart, J. M., Vidaud, M., Frankenne, F., and Evain-Brion, D. (2002) Effect of Matrigel on human extravillous trophoblasts differentiation: modulation of protease pattern gene expression. Biol. Reprod. 67, 1628-1637
64. Anacker, J., Segerer, S. E., Hagemann, C., Feix, S., Kapp, M., Bausch, R., and Kämmerer, U. (2011) Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases. Mol. Hum. Reprod. 17, 637-652
65. Huppertz, B., Kertschanska, S., Demir, A. Y., Frank, H. G., and Kaufmann, P. (1998) Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res. 291, 133-148
66. Chamberlain, S. H., Hemmer, R. M., and Brinckerhoff, C. E. (1993) Novel phorbol ester response region in the collagenase promoter binds Fos and Jun. J. Cell. Biochem. 52, 337-351
67. Westermarck, J., Seth, A., and Kähäri, V. M. (1997) Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14, 2651-2660